tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Innate Pharma price target lowered to $11 from $11.50 at H.C. Wainwright
PremiumThe FlyInnate Pharma price target lowered to $11 from $11.50 at H.C. Wainwright
5M ago
Innate Pharma announces EUR 15M capital increase from Sanofi
Premium
The Fly
Innate Pharma announces EUR 15M capital increase from Sanofi
5M ago
Innate Pharma regains rights to Anket, announces potential Sanofi investment
Premium
The Fly
Innate Pharma regains rights to Anket, announces potential Sanofi investment
5M ago
Innate Pharma appoints Jonathan Dickinson as CEO
PremiumThe FlyInnate Pharma appoints Jonathan Dickinson as CEO
11M ago
Innate Pharma announces FDA clearance of IPH4502 IND
Premium
The Fly
Innate Pharma announces FDA clearance of IPH4502 IND
12M ago
Innate Pharma reports AstraZeneca presentation of results from NeoCOAST-2 study
Premium
The Fly
Innate Pharma reports AstraZeneca presentation of results from NeoCOAST-2 study
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100